One stage and chromogenic assays discrepancy in the estimation of Factor IX recovery: What single hemophilia center can and what cannot do?

被引：0
|
作者：
Antovic, Jovan [1 ,2 ]
Perssons, Asa [1 ,2 ]
Soutari, Nida [1 ,2 ]
Norberg, Eva-Marie [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Clin Chem, Coagulat, Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M-FPMED01-
引用
收藏
页码：51 / 51
页数：1
相关论文
共 33 条
  • [21] Power spectral density of a single Brownian trajectory: what one can and cannot learn from it
    Krapf, Diego
    Marinari, Enzo
    Metzler, Ralf
    Oshanin, Gleb
    Xu, Xinran
    Squarcini, Alessio
    NEW JOURNAL OF PHYSICS, 2018, 20
  • [22] Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype
    Oldenburg, J.
    Pavlova, A.
    HAMOSTASEOLOGIE, 2010, 30 (04): : 207 - 211
  • [23] Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays
    Pavlova, Anna
    Delev, Daniel
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Oldenburg, Johannes
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 851 - 861
  • [24] FACTOR VIII LEVEL COMPARISON IN PATIENTS WITH SEVERE HEMOPHILIA A ON EMICIZUMAB WITH INHIBITORS WITH ONE STAGE, BOVINE AND HUMAN CHROMOGENIC ASSAYS AND THE FACTOR VIII EQUIVALENCY OF EMICIZUMAB USING IN VIVO GLOBAL HEMOSTASIS ASSAYS
    Kizilocak, Hande
    Marquez-Casas, Elizabeth
    Brown, Joshua
    Malvar, Jemily
    Young, Guy
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E58 - E58
  • [25] Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency of Emicizumab Using In Vivo Global Hemostasis Assays
    Kizilocak, Hande
    Marquez-Casas, Elizabeth
    Brown, Joshua
    Malvar, Jemily
    Young, Guy
    BLOOD, 2021, 138
  • [26] Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study
    Bowyer, A. E.
    Hillarp, A.
    Ezban, M.
    Persson, P.
    Kitchen, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) : 1428 - 1435
  • [27] What we can do with one qubit in quantum machine learning: ten classical machine learning problems that can be solved with a single qubit
    Cuellar, Manuel P.
    QUANTUM MACHINE INTELLIGENCE, 2024, 6 (02)
  • [28] Comparison of Post Treatment Monitoring of New And Old Factor VIII (FVIII) Therapeutic Products By One-Stage Clotting and Chromogenic FVIII Assays: Single Centre Experience
    Riddell, A.
    Gandhi, T.
    Vinayagam, S.
    Lawler, P.
    Pollard, T.
    Chowdary, P.
    HAEMOPHILIA, 2016, 22 : 86 - 87
  • [29] Centenarians with Cerebrovascular Disease: 38 Patients from a Single Center. How much do we know? What can we improve?
    Dragomir, Roxana
    Carranza-Renteria, Octavio
    Babici, Denis
    Miles-Kiple, Lesli
    Kent, Kendra
    Barratt, Diana
    NEUROLOGY, 2023, 100 (17)
  • [30] Single dose pharmacokinetic evaluation of ReFacto, the B domain-deleted recombinant factor VIII (BDDrFVIII), using one-stage and chromogenic assays: Comparison between plasma and concentrate laboratory standards.
    Morfini, M
    Cinotti, S
    Paladino, E
    Mannucci, PM
    Bellatreccia, A
    Bianchi, C
    BLOOD, 2000, 96 (11) : 490A - 490A
1234